| BMD | Bone mineral density |
| BV/TV | bone volume/Total volume |
| Tb.Ar | Trabecular Area |
| Tb.Th | Trabecular thickness |
| Tb.N | Trabecular Number |
| Tb.Sp | Trabecular space |
| Ct. Vol | Cortical Volume |
| Ct. Th | Cortical Thickness |
| ALP | Alkaline phosphatase |
| OCN | Osteocalcin |
| SIRT1 | silent information regulator of transcription 1 |
| Akt | Ak strain transforming |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| TNFα | tumour necrosis factor alpha |
| ROS | Reactive Oxygen Species |
| MDA | Malondialdehyde |
| SOD | Superoxide dismutase |
| GSH | Glutathione |
| FoxO1 | Forkhead box O1 |
| PI3K/Akt | phosphatidylinositol-3-kinase |
| RANK | Receptor activator of nuclear factor κB |
| RANKL | receptor activator of nuclear factor-κB ligand |
| OPG | osteoprotegrin |
| TRAP | tartrate-resistant acid phosphatase |
| IL-6 | Interleukin-6 |
| IL-1β | Interleukin-1beta |
| CTX-1 | C-terminal telopeptides type I collagen |
| CtsK | Cathepsin K |
| NFATc1 | nuclear factor-activated T cells |
| Nrf2 | nuclear factor E2-related factor 2 |
| BMP2 | bone morphogenic protein 2 |
| Osx | Osterix |
| Col1a1 | alpha-1 type I collagen |
| P1NP | amino-terminal propeptide of type 1 procollagen |
| RunX2 | runt-related transcription factor 2 |
| BMSC | bone mesenchymal stem cells; |
| HBMSC | Human bone mesenchymal stem cells |
| PGE2 | prostaglandin E2 |
| MAP kinase | mitogen-activated protein kinase |
| SAPK/JNK | stress-activated protein kinase/c-Jun N-terminal kinase |
| AMPK | AMP-activated protein kinase |
| ONN | Osteonectin |
| OCN | Osteocalcin |
| ONN | Osteonectin |
| MMP | matrix metalloproteinase |
| GSK-3b | Glycogen synthase kinase-3 beta |
| ERK | extracellular signal-regulated kinase |
| CREB | cyclic AMP-responsive element-binding protein |
| LPS | Lipopolysaccharide |
| NO | nitric oxide |
| iNOS | inducible nitric oxide synthase |
| COX-2 | cyclooxygenase 2 |
| LDH | Lactate Dehydrogenase |
| PINP | Procollagen type I N-terminal propeptide |